Tech Company Financing Transactions

Xanodyne Pharmaceuticals Funding Round

On 6/1/2004, Xanodyne Pharmaceuticals raised $20 million in Series C funding from EW Healthcare Partners, Blue Chip Venture Company and HealthCare Ventures.

Transaction Overview

Announced On
6/1/2004
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series C
Proceeds Purpose
The proceeds of the financing will be used to expand its national field sales team and fund its development programs for Misopess (for cervical ripening) and XP012B (for menorrhagia), both of which will enter Phase III later this year.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
One Riverfront Place
Newport, KY 41071
USA
Email Address
Overview
Xanodyne is a specialty pharmaceutical company with commercial and development capabilities for providing better patient care in women's health and pain management.
Profile
Xanodyne Pharmaceuticals LinkedIn Company Profile
Social Media
Xanodyne Pharmaceuticals Company Twitter Account
Company News
Xanodyne Pharmaceuticals News
Facebook
Xanodyne Pharmaceuticals on Facebook
YouTube
Xanodyne Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Natasha Giordano
  Natasha Giordano LinkedIn Profile  Natasha Giordano Twitter Account  Natasha Giordano News  Natasha Giordano on Facebook
Chief Financial Officer
Rita O'Connor
  Rita O'Connor LinkedIn Profile  Rita O'Connor Twitter Account  Rita O'Connor News  Rita O'Connor on Facebook
Chief Operating Officer
Fabrice Egros
  Fabrice Egros LinkedIn Profile  Fabrice Egros Twitter Account  Fabrice Egros News  Fabrice Egros on Facebook
VP - Regulatory Affairs
Thomas Jennings
  Thomas Jennings LinkedIn Profile  Thomas Jennings Twitter Account  Thomas Jennings News  Thomas Jennings on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/1/2004: Virtusa venture capital transaction
Next: 6/2/2004: NorthStar Systems International venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document tech company VC transactions. All VC database entries reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary